ME/CFS Research Summaries

Tag: ➕-2026-05-03✕

17 items with this tag.

Apr 29, 2026
Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluation
- ➕-2026-05-03
- 💊-Treatment
Apr 27, 2026
Cardiopulmonary Exercise Testing Reveals Functional Limitations and Work Disability in Severe Post-COVID-19 and ME/CFS Patients
- ➕-2026-05-03
- 🧪-Biomarker
Apr 27, 2026
Regulatory Cycles of Orexin and Glucagon-Like Peptide-1 in Post-Viral Syndromes
Apr 24, 2026
A Window Into Mitochondrial Dysfunction in Myalgic Encephalitis/Chronic Fatigue Syndrome (ME/CFS): Increased Lactate Production During Brain Stimulation With a Flashing Checkerboard Using 7T Functional MRS
Apr 21, 2026
Insights into Pathophysiological Pathways in ME/CFS Through Genetic Correlation and Mendelian Randomization
Apr 14, 2026
Shear Stress Tolerance Threshold, eNOS Uncoupling, and the Two-Threshold Model of Post-Exertional Malaise in Long COVID: A Mechanistic Hypothesis with Implications for Physiotherapy Practice
Apr 13, 2026
Hypoarousal state as a critical condition in neurocognitive impairment in SARS-CoV-2 associated ME/CFS
- ➕-2026-05-03
- 🧪-Biomarker
Apr 12, 2026
Comprehensive Immunophenotyping of Monocytes and Dendritic Cells Suggests Distinct Pathophysiology in Chronic Fatigue Syndrome and Long COVID
- ➕-2026-05-03
- 🧪-Biomarker
Apr 07, 2026
Perioperative outcomes in myalgic encephalomyelitis/chronic fatigue syndrome undergoing general anesthesia: a retrospective matched-pair study
- ➕-2026-05-03
- 💊-Treatment
Apr 01, 2026
Impaired peripheral oxygen delivery during submaximal exercise in adults with long COVID
- ➕-2026-05-03
- 🧪-Biomarker
Mar 28, 2026
Pathophysiological, Translational, and Diagnostic Aspects of ME/CFS: A Focus on Skeletal Muscle Involvement
- ➕-2026-05-03
- 🧪-Biomarker
Mar 23, 2026
Microtesla Magnetic Therapy for cognitive impairment in post-acute sequelae of SARS CoV-2: A randomized controlled feasibility study
- ➕-2026-05-03
- 💊-Treatment
Mar 22, 2026
Autoantibody landscapes in neurological Long COVID and post-COVID cognitive impairment show heterogeneity without a shared disease signature
- ➕-2026-05-03
- 🧪-Biomarker
Mar 09, 2026
A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002 in people with Long COVID
Feb 24, 2026
Association of G-Protein-Coupled Receptors autoantibodies with vasoregulation in Post-COVID
- ➕-2026-05-03
- 🧪-Biomarker
Jul 01, 2025
Utilizing Wearable Technology to Characterize and Predict Post-Exertional Malaise Crashes across Post-COVID Syndrome and Chronic Inflammatory Conditions: Study Protocol of the prospective observational study 'U-WaTCH'
Jun 19, 2024
A causal link between autoantibodies and neurological symptoms in long COVID

Created with Quartz v4.5.2 © 2026

Home
GitHub
Imprint